Benzinga's Top Pre-Market Gainers
Vanda Pharmaceuticals (NASDAQ: VNDA) moved up 25.47% to $10.10 in the pre-market session after the FDA accepted the filing and granted a priority review classification to the company's New Drug Application for tasimelteon for the treatment of Non-24-Hour Disorder in the totally blind.
Aegerion Pharmaceuticals (NASDAQ: AEGR) soared 11.38% to $86.02 in the pre-market trading on Q2 results.
L & L Energy (NASDAQ: LLEN) surged 10.12% to $3.70 in the pre-market session after company announced fiscal year end 2013 results.
Goodyear Tire & Rubber Co (NASDAQ: GT) shares gained 7.16% to $18.26 in the pre-market session after the company reported a strong rise in its second-quarter net income.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.